In the course of our screening program to discover antimalarial antibiotics, which are active against drug resistant Plasmodium falciparum in vitro and rodents infected with P. berghei in vivo, from the culture broth of microorganisms, we found a selective and potent active substance produced by an actinomycete strain K99-0413. It was identified as a known polyether antibiotic, X-206. We also compared the in vitro antimalarial activities and cytotoxicities of 12 known polyethers with X-206. Amongthem, X-206 showed the most selective and potent inhibitory effect against both drug resistant and sensitive strains of P. 
In the course of our screening program to discover antimalarial antibiotics, which are active against drug resistant Plasmodium falciparum in vitro and rodents infected with P. berghei in vivo, from the culture broth of microorganisms, we found a selective and potent active substance produced by an actinomycete strain K99-0413. It was identified as a known polyether antibiotic, X-206. We also compared the in vitro antimalarial activities and cytotoxicities of 12 known polyethers with X-206. Amongthem, X-206 showed the most selective and potent inhibitory effect against both drug resistant and sensitive strains of P.
falciparum. Comparison of biological activities and ion-affinities of the above antibiotics suggests that monovalent cations play an important biological role for the intracellular growth of P. falciparum in parasitized erythrocytes. Moreover, X-206 showed potent in vivo antimalarial activity on the rodent model, though the therapeutic windowwas narrow compared with its selective toxicity in vitro. These observations are the first report of antimalarial activity ofX-206. Malaria has had a resurgence in manytropical areas.
This disease now occurs in more than 90 countries worldwide, and it is estimated there are over 500 million clinical cases and 2.7 million malaria-caused deaths per year1^Furthermore, the spread of Plasmodium falciparum strains resistant to antimalarials such as chloroquine indicates that new antimalarials having novel structures and mechanisms of action are needed for chemotherapeutic control of this disease. In the course of our screening program to discover antimalarial antibiotics, which are active against drug resistant parasites in vitro and in vivo from soil microorganisms, an actinomycete strain K99-0413 was found to produce a known polyether antibiotic, X-206 ( Fig. 1) 2). 4-5 years ago, Gumila et al. reported that 22 ionophore compounds including 1 7 polyether antibiotics showedin vitro antimalarial activities against drug sensitive strain of P. falciparum and 7 polyether antibiotics among them showed in vivo antimalarial activities3 '4) .
Here, we describe the results of the sensitivity tests of the Kl and FCR3 strains against known antimalarial drugs under our in vitro assay condition, the antimalarial activities and cytotoxicities of 13 polyether antibiotics including X- DMSO)was added. After incubation at 37°C for 72 hours under 93% N2, 4% CO2, and 3% O2, the plate was immediately frozen at -20°C for 18 hours. The plate was then thawed at 37°C, and 20^1 of the haemolyzed parasite suspension was transferred to another plate containing lOO /il of Malstat reagent. The plate was further incubated for 15 minutes at room temperature, and 20^1 of a 1:1 mixture of nitroblue tetrazolium and phenazine ethosulfate (2mg and 0.1 mg/ml respectively) was added to each well. After incubation for 2 hours at room temperature in the dark condition, the blue formazan product was measured at 655 nm by an iEMS microplate reader MF(Labosystems, Helsinki, Finland). The 50% inhibitory concentration (IC50) value wasestimated froma dose responsecurve.
Cytotoxicity Tests on MRC-5Cells
A human diploid embryonic cell line, MRC-5was a parasitized red blood cells intravenously. Test compounds were dissolved in 10%DMSOsolution and subcutaneously (s.c.) injected to the mice two hours after the infection (day 0). Test compounds were successively injected (s.c.) to the mice once a day for 3 consecutive days (Days 1-3 ). Five mice were tested at each dosage, and another 5 infected mice were injected with 10% DMSO-wateras a control.
The day after the last treatment (Day 4), thin blood films were made from the tail blood of the infected mice, and the parasitaemia was determined. The 50% effective dose (ED50) was estimated from a dose response curve. The values were tested for statistical significance by Dunnett protocol.
Results and Discussion

Sensitivity of Plasmodial Strains against Antimalarial Drugs
The Kl strain which is known to be resistant to choloroquine, quinine and pyrimethamine. On the other hand, the FCR3strain which is known to be susceptible to choloroquine, quinine and pyrimethamine. First, we studied the sensitivity of the Kl and FCR3strains against known antimalarial drugs under our in vitro assay condition. The effects of 8 clinically used antimalarials on the drug resistant Kl strain and the drug sensitive FCR3strain of P. falciparum were studied and their 50% inhibitory concentrations (IC50s) were determined as shown in Table   1 . Among the tested compounds, the derivatives from artemisinin, artemether and artesunate showed the most potent antimalarial activity against both strains. The drug effects of chloroquine, pyrimethamine, and trimethoprim against the Kl strain were lower about 12 fold, >12,820 fold and >714 fold, respectively, than those against the FCR3 strain. So the Kl strain exhibited resistance to chloroquine and also to pyrimethamine and trimethoprim, which are inhibitors of the parasite dihydrofolate reductase.
In Vitro Antimalarial Activities and Cytotoxicities of Polyether Antibiotics
The effects of 13 polyether antibiotics including K99- ND *** * drug resistance strain, ** drug sensitive strain, *** determined by Pressman12), Westley13) and Bolte et ah 14), **** not determined.
X-206 showed lower cytotoxicities than the others with the IC50 values of 1,648 nM, l,1 12nM, and 551 nM, respectively. To compare the antimalarial activities and cytotoxicities, we introduced the selectivity indexes (cytotoxicity [IC50 for the MRC-5cellsj/antimalarial activity [IC50 for the Kl strain or the FCR3strain]) as listed in Table 2 Table 2 . Class 1 polyether antibiotics, which are specific to monovalent cations, had the highest antimalarial activities (IC50<2.7 nM for the Kl strain). Class 2 polyether antibiotics, which are able to complex with both mono and divalent cations, had moderate antimalarial activities (IC50<65 nMfor the Kl strain). Class 3 polyether antibiotics, which are specific to divalent cations, had weak antimalarial activities (IC505 87nM for the Kl strain). As for the selectivity indexes of the MRC-5 cells/Kl strain, class 1 polyether antibiotics except monensin showed good values {>34). Class 2 polyether antibiotics showed moderate indexes (20-25).
Class 3 polyether antibiotics showed the lowest selectivity indexes (0.9~1.8).
The present results including the selectivity indexes of the MCR-5cells/FCR3 strain were similar to the results of Gumiia et al?\ Therefore, the monovalent cations may also play the important biological role for the intracellular growth of drug resistant P. falciparum in parasitized erythro cyte s.
The complexation affinity for various cations of octacyclomycin had not been measured and therefore classified to the unknown class. Octacyclomycin is a diglycoside polyether antibiotic, and structurally similar to the monoglycoside polyether antibiotics, etheromycin and antibiotic-6016.
Because etheromycin is specific for monovalent cations15), and the antibiotic-6016 is able to complex with both mono and divalent cations16), octacyclomycin may be classified to class 1 or 2 from the results of its antimalarial activity and cytotoxicity.
In Vivo Antimalarial Activities of X-206, Artemether and Artesunate in Mice The subcutaneously administration of X-206 and the clinically used compounds, artemether and artesunate, were evaluated by using the P. berghei strain N (drug sensitive strain) infected mice. Their ED50 values are listed in Table  3 . X-206 showed the highest in vivo antimalarial activities among the tested compounds, but X-206 was toxic beyond 3 mg/kg (data not shown). The acute toxicity (LD50, s.c.) of X-206 for mice was 1 1 mg/kg, which has been reported by Berger, shown to be very active against P. vinckei petteri or P. chabaudi in mice after oral or intraperitoneal administration^.
Recently, Adovelande and Schrevel reported that the combination of nigericin and monensin using the lower doses showed a synergistic effect on the rodent malaria model in vivoll\ These observations suggest the possibility of using X-206 in combination therapy for malaria chemotherapy.
